TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
23,090
|
14,546
|
13,020 |
| Financial expenses |
118
|
57
|
1 |
| Earnings before taxes |
5,212
|
-3,969
|
-5,183 |
| EBITDA |
4,673
|
-4,294
|
-5,280 |
| Total assets |
30,626
|
25,316
|
21,037 |
| Current assets |
28,976
|
23,198
|
18,814 |
| Current liabilities |
22,429
|
22,346
|
17,122 |
| Equity capital |
8,197
|
2,970
|
3,915 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
16
|
16
|
14 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
26.8%
|
11.7%
|
18.6% |
| Turnover per employee |
1,443
|
909
|
930 |
| Profit as a percentage of turnover |
22.6%
|
-27.3%
|
-39.8% |
| Return on assets (ROA) |
17.4%
|
-15.5%
|
-24.6% |
| Current ratio |
129.2%
|
103.8%
|
109.9% |
| Return on equity (ROE) |
63.6%
|
-133.6%
|
-132.4% |
| Change turnover |
8,469
|
2,581
|
564 |
| Change turnover % |
58%
|
22%
|
5% |
| Chg. No. of employees |
0
|
2
|
1 |
| Chg. No. of employees % |
0%
|
14%
|
8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.